Welcome to our dedicated page for Lifeway Food news (Ticker: LWAY), a resource for investors and traders seeking the latest updates and insights on Lifeway Food stock.
Lifeway Foods, Inc. (NASDAQ: LWAY) is a U.S. manufacturer of probiotic, cultured and fermented dairy foods best known for its drinkable kefir, cheeses and ProBugs products for kids. This news page aggregates coverage of the company’s announcements, regulatory disclosures and shareholder communications so readers can follow developments affecting the LWAY stock and the underlying business.
Company news releases highlight Lifeway’s role as America’s leading supplier of the probiotic, fermented beverage known as kefir and as a leading U.S. supplier of kefir and fermented probiotic foods. Recent items include product innovation such as the planned launch of Probiotic Kefir Butter™, which extends the company’s cultured dairy expertise into spreadable European-style butter, as well as updates on sales trends and volume growth for its kefir portfolio.
Investors can also find governance and capital markets news, including details of a Cooperation Agreement with Danone North America PBC, board refreshment steps, amendments to a shareholder rights plan and proxy-related communications involving Institutional Shareholder Services and significant shareholders. These stories provide context on how Lifeway’s board structure, shareholder base and strategic options are evolving.
In addition, Lifeway’s news flow covers participation in investor conferences, commentary on federal dietary guidelines that reference kefir and fermented foods, and other corporate updates. By reviewing this page, readers can see how product initiatives, governance developments and financial disclosures intersect for Lifeway Foods, Inc. and its LWAY listing on the Nasdaq Global Market.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Julie Smolyansky, CEO of Lifeway Foods (NASDAQ: LWAY), recently featured on ICR's podcast 'Welcome to the Arena.' In this episode, she discussed the company's history, her transition to CEO, and future product developments. Lifeway Foods specializes in kefir and other fermented probiotic products, aiming to support the microbiome. The podcast, which has aired since August 2021, showcases influential figures in various industries, discussing strategies that create value for companies. Lifeway Foods has garnered recognition, including being listed among Forbes' Best Small Companies.
Lifeway Foods, Inc. (Nasdaq: LWAY) reported record net sales of $141.5 million for 2022, marking an 18.9% year-over-year increase and a 51.1% rise compared to 2019. This achievement represents the 13th consecutive quarter of growth in net sales. The growth was primarily driven by increased sales of their branded drinkable kefir and price adjustments. Despite rising costs, gross profit was 18.9% of net sales, with selling expenses lower at 16.9%. However, net income decreased to $0.9 million from $3.3 million in 2021. The company plans to pursue further distribution and marketing efforts in 2023.
Lifeway Foods, Inc. (NASDAQ: LWAY), a prominent U.S. supplier of kefir and probiotic products, will announce its financial results for the fourth quarter and full year ending December 31, 2022. The report is scheduled for March 27, 2023, after market hours. Following the results, a conference call led by CEO Julie Smolyanksy will be available on the company's Investor Relations webpage. Lifeway, recognized as one of Forbes' Best Small Companies, offers a diverse range of products, including drinkable kefir, cheese, and probiotic oat milk, available across the U.S., Mexico, Ireland, and France.
FAQ
What is the current stock price of Lifeway Food (LWAY)?
What is the market cap of Lifeway Food (LWAY)?
